T-cell immunoglobulin and mucin domain-3 (TIM-3) is an activation-induced inhibitory receptor and binds to its ligand galectin-9 (Gal-9) to induce immune tolerance and T-cell exhaustion in cancer [84]. Here, LGALS9 is linked to cancer.